| Literature DB >> 27352075 |
Rebecca Klein1,2, Nicolas Mahlberg3, Maurice Ohren3, Anne Ladwig3,4, Bernd Neumaier4,5, Rudolf Graf4, Mathias Hoehn4, Morten Albrechtsen6, Stephen Rees6, Gereon Rudolf Fink3,7, Maria Adele Rueger3,4,7, Michael Schroeter3,4,7.
Abstract
The neural cell adhesion molecule (NCAM)-derived peptide FG loop (FGL) modulates synaptogenesis, neurogenesis, and stem cell proliferation, enhances cognitive capacities, and conveys neuroprotection after stroke. Here we investigated the effect of subcutaneously injected FGL on cellular compartments affected by degeneration and regeneration after stroke due to middle cerebral artery occlusion (MCAO), namely endogenous neural stem cells (NSC), oligodendrocytes, and microglia. In addition to immunohistochemistry, we used non-invasive positron emission tomography (PET) imaging with the tracer [18F]-fluoro-L-thymidine ([18F]FLT) to visualize endogenous NSC in vivo. FGL significantly increased endogenous NSC mobilization in the neurogenic niches as evidenced by in vivo and ex vivo methods, and it induced remyelination. Moreover, FGL affected neuroinflammation. Extending previous in vitro results, our data show that the NCAM mimetic peptide FGL mobilizes endogenous NSC after focal ischemia and enhances regeneration by amplifying remyelination and modulating neuroinflammation via affecting microglia. Results suggest FGL as a promising candidate to promote recovery after stroke.Entities:
Keywords: FG loop; NCAM; NCAM-derived peptide; Neuroinflammation; Positron-emission-tomography; Regeneration; Stroke; [18F]-fluoro-L-thymidine
Mesh:
Substances:
Year: 2016 PMID: 27352075 DOI: 10.1007/s11481-016-9694-5
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147